Fig. 6: Epitope-specific CD8+ T-cell magnitude before and after omicron infection in vaccinated SARS-CoV-2-naive and previously-infected individuals. | Nature Communications

Fig. 6: Epitope-specific CD8+ T-cell magnitude before and after omicron infection in vaccinated SARS-CoV-2-naive and previously-infected individuals.

From: Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history

Fig. 6: Epitope-specific CD8+ T-cell magnitude before and after omicron infection in vaccinated SARS-CoV-2-naive and previously-infected individuals.

a Magnitude of multimer-specific CD8+ T cells expressed as a % of total CD8+ cells following mRNA vaccine dose 3 (pre-omicron) and after omicron infection (pooled data from Sheffield and Newcastle). Shown are 63 spike-specific multimer populations from 45 individuals (23 naive, 22 previously-infected), 24 non-spike populations from 20 individuals (10 naive, 10 previously-infected), 15 CMV-specific populations from 15 individuals, and 41 EBV-specific populations from 32 individuals. A value of 0.0001% is assigned to negative samples for the purpose of display on a log10 axis. b Representative flow cytometry plots showing multimer-specific spike- and non-spike CD8+ populations from naive and previously-infected individuals before and after omicron infection. Data are shown with median and interquartile range. Statistical comparisons of paired pre- and post-infection samples where available from the same participants were made with two-sided Wilcoxon-signed-rank test, and between unpaired groups using the Kruskal–Wallis test with Dunn’s post hoc test for multiple pairwise comparisons. p-values are >0.05 unless displayed. Source data are provided as a Source Data file.

Back to article page